Amalgamated Bank Iovance Biotherapeutics, Inc. Transaction History

Amalgamated Bank

$12.1 Billion
Q3 2024

A detailed history of Amalgamated Bank transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Amalgamated Bank holds 8,331 shares of IOVA stock, worth $71,230. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,331

Previous 8,331 -0.0%

Holding current value

$71,230

Previous $67,000 16.42%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$7.78 - $14.19 $2,046 - $3,731	263 Added 3.26%	8,331 $67,000
Q1 2024 Apr 23, 2024	SELL	$7.59 - $17.47 $97,668 - $224,803	-12,868 Reduced 61.46%	8,068 $120,000
Q4 2023 Feb 06, 2024	SELL	$3.3 - $8.89 $4,521 - $12,179	-1,370 Reduced 6.14%	20,936 $170,000
Q3 2023 Nov 08, 2023	BUY	$4.44 - $8.79 $19,686 - $38,974	4,434 Added 24.81%	22,306 $101,000
Q2 2023 Aug 11, 2023	BUY	$5.36 - $9.06 $12,440 - $21,028	2,321 Added 14.93%	17,872 $125,000
Q1 2023 May 02, 2023	SELL	$5.53 - $8.22 $20,361 - $30,266	-3,682 Reduced 19.14%	15,551 $95,000
Q3 2022 Nov 09, 2022	BUY	$9.53 - $13.11 $1,782 - $2,451	187 Added 0.98%	19,233 $184,000
Q2 2022 Aug 15, 2022	SELL	$6.38 - $18.33 $62,530 - $179,652	-9,801 Reduced 33.98%	19,046 $210,000
Q1 2022 Jun 30, 2022	BUY	$12.38 - $19.1 $7,836 - $12,090	633 Added 2.24%	28,847 $480,000
Q4 2021 Feb 15, 2022	BUY	$16.55 - $27.63 $25,056 - $41,831	1,514 Added 5.67%	28,214 $539,000
Q3 2021 Oct 29, 2021	SELL	$20.35 - $26.63 $22,181 - $29,026	-1,090 Reduced 3.92%	26,700 $658,000
Q2 2021 Aug 16, 2021	BUY	$16.33 - $33.07 $35,240 - $71,365	2,158 Added 8.42%	27,790 $723,000
Q1 2021 May 13, 2021	SELL	$28.67 - $52.59 $64,048 - $117,486	-2,234 Reduced 8.02%	25,632 $812,000
Q4 2020 Feb 12, 2021	SELL	$28.04 - $50.26 $168 - $301	-6 Reduced 0.02%	27,866 $1.29 Million
Q3 2020 Oct 30, 2020	SELL	$27.75 - $36.3 $4,939 - $6,461	-178 Reduced 0.63%	27,872 $918,000
Q2 2020 Aug 10, 2020	BUY	$27.21 - $41.0 $189,109 - $284,950	6,950 Added 32.94%	28,050 $770,000
Q1 2020 May 13, 2020	SELL	$19.54 - $38.85 $18,250 - $36,285	-934 Reduced 4.24%	21,100 $632,000
Q4 2019 Feb 13, 2020	BUY	$17.95 - $29.41 $31,179 - $51,085	1,737 Added 8.56%	22,034 $610,000
Q3 2019 Nov 13, 2019	SELL	$17.99 - $26.0 $4,713 - $6,812	-262 Reduced 1.27%	20,297 $369,000
Q2 2019 Aug 14, 2019	BUY	$9.78 - $24.52 $51,775 - $129,808	5,294 Added 34.68%	20,559 $504,000
Q1 2019 May 15, 2019	BUY	$8.41 - $11.26 $5,306 - $7,105	631 Added 4.31%	15,265 $145,000
Q4 2018 Feb 15, 2019	BUY	$7.51 - $11.93 $109,901 - $174,583	14,634 New	14,634 $130,000
Q3 2018 Nov 14, 2018	SELL	$11.25 - $17.7 $141,513 - $222,648	-12,579 Closed	0 $0
Q2 2018 Jul 18, 2018	BUY	$12.45 - $16.95 $156,608 - $213,214	12,579 New	12,579 $161,000

Others Institutions Holding IOVA

# of Institutions

314

Shares Held

241M

Call Options Held

3.77M

Put Options Held

1.7M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.35B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Account

Amalgamated Bank Iovance Biotherapeutics, Inc. Transaction History